Epitiostanol is a synthetic steroid antiestrogen and antineoplastic agent used primarily in the medical treatment of breast cancer by blocking estrogen receptors to inhibit tumor growth. As a potent inhibitor,… Read more
Epitiostanol is a synthetic steroid antiestrogen and antineoplastic agent used primarily in the medical treatment of breast cancer by blocking estrogen receptors to inhibit tumor growth. As a potent inhibitor, it prevents the conversion of androgens to estrogens, a critical mechanism in managing hormone-responsive malignancies. Laboratories rely on high-quality reference standards of this compound, alongside its corresponding pharmaceutical impurities, metabolites, and stable isotope labelled compounds, to ensure precision in analytical testing. These reference materials are essential for conducting rigorous impurity profiling, verifying the accuracy of chromatographic methods, and supporting quality control protocols throughout the pharmaceutical development lifecycle. By utilizing these characterized standards, researchers can confidently validate quantitative assays and maintain compliance with stringent regulatory requirements during the rigorous assessment of drug purity and stability.